Pulmonary Rehabilitation Outcomes of Post-Acute COVID-19 Patients during Different Waves of the Pandemic
-
Published:2023-05-22
Issue:10
Volume:20
Page:5907
-
ISSN:1660-4601
-
Container-title:International Journal of Environmental Research and Public Health
-
language:en
-
Short-container-title:IJERPH
Author:
Spielmanns Marc12ORCID, Schaer Corina E.1ORCID, Pekacka-Egli Anna-Maria1, Spielmanns Sabine1, Ibish Olberk1, Gafina Guzel1, Stiube Antonela1, Hermann Matthias3ORCID
Affiliation:
1. Pulmonary Medicine, Zuercher RehaZentren, Klinik Wald, 8636 Wald, Switzerland 2. Department for Pulmonary Medicine, Faculty of Health, University Witten Herdecke, 58455 Witten, Germany 3. Department of Cardiology, University Heart Center, University Hospital Zurich, 8006 Zurich, Switzerland
Abstract
(1) Background: Between the beginning of the coronavirus pandemic and summer 2022, we distinguished four pandemic waves, with different characteristics of the affected patients. This study investigated the impact of patient characteristics on the outcome of inpatient pulmonary rehabilitation (PR). (2) Methods: Using a prospective approach, the characteristics of post-acute COVID-19 patients of the different waves who participated in inpatient PR were compared based on their assessments and results collected as part of PR (Cumulative Illness Rating Scale (CIRS), six-minute walk test (6-MWT), Pulmonary Function Testing (PFT), and Functional Independent Measurement (FIM). (3) Results: A total of 483 patients were included in the analysis (Wave 1 n = 51, Wave 2 n = 202, Wave 3 n = 84, Wave 4 n = 146). Compared to Wave 3 + 4, patients of Wave 1 + 2 were older (69 vs. 63 years; p < 0.001), had a significantly lower CIRS (13.0 vs. 14.7 points; p = 0.004), had significant better PFT (FVC: 73 vs. 68%pred; p = 0.009; DLCOSB: 58 ± 18 vs. 50 ± 17%pred; p = 0.001), and showed significantly more comorbidities (2.0 vs. 1.6 n/pers.; p = 0.009). Wave 3 + 4 showed significantly greater improvements according to the 6-MWT (147 vs. 188 m; p < 0.001) and the FIM (5.6 vs. 21.1 points; p < 0.001). (4) Conclusions: Patients of the COVID-19 infection waves differed significantly according to their anthropometric data, incidence of comorbidities, and impact of the infection. All cohorts achieved clinically relevant and significant functional improvements during PR, with significant higher improvements in Wave 3 + 4.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference32 articles.
1. (2022, December 28). Pneumonia of Unknown Cause–China. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229. 2. (2022, December 28). Entwicklung der Coronavirus-Epidemie (COVID-19) in der Schweiz seit Februar 2020. Available online: https://de.statista.com/statistik/daten/studie/1101371/umfrage/entwicklung-der-fallzahlen-des-coronavirus-in-der-schweiz/. 3. COVID-19 acute respiratory distress syndrome (ARDS): Clinical features and differences from typical pre-COVID-19 ARDS;Gibson;Med. J. Aust.,2020 4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study;Zhou;Lancet,2020 5. Silverio, A., Di Maio, M., Citro, R., Esposito, L., Iuliano, G., Bellino, M., Baldi, C., De Luca, G., Ciccarelli, M., and Vecchione, C. (2021). Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: Systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc. Disord., 21.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|